Advertisement

Current Fungal Infection Reports

, Volume 7, Issue 3, pp 192–197 | Cite as

Candida africana: Is It a Fungal Pathogen?

  • Orazio Romeo
  • Hans-Jürgen Tietz
  • Giuseppe Criseo
Clinical Lab Issues (M Brandt, Section Editor)

Abstract

Twelve years ago, Candida africana was proposed as new species within the Candida albicans species complex, and since then has raised much controversy regarding whether or not it should be considered a separate species from C. albicans. Although its taxonomic status is still a matter of debate, this yeast differs from C. albicans by a number of phenotypic, genotypic, pathogenic and clinical characteristics that make this fungus particularly interesting to study. Current epidemiological and clinical data suggest that C. africana has a worldwide distribution, is particularly adapted to colonize/infect human vaginal mucosa, and may also be responsible for most serious diseases involving other human organs. In this review, we will discuss the current knowledge about C. africana, highlighting its role in human infections, thus providing a complete clinical picture in order to understand if this yeast can be considered an important pathogen.

Keywords

Candidiasis Candida africana Candida albicans Candida dubliniensis Chlamydospore negative Atypical Candida strains Molecular identification Epidemiology Vaginal infections Vaginitis Antifungals 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Orazio Romeo declares that he has no conflict of interest.

Hans-Jürgen Tietz declares that he has no conflict of interest.

Giuseppe Criseo declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • of importance •• of major importance

  1. 1.
    Brandt ME, Lockhart SR. Recent taxonomic developments with Candida and other opportunistic yeasts. Curr Fungal Infect Rep. 2012;6:170–7.CrossRefGoogle Scholar
  2. 2.
    Lachance MA, Boekhout T, Scorzetti G, Fell JW, Kurtzman CP. Candida Berkhout (1923). In: Kurtzman CP, Fell JW, Boekhout T, editors. The yeasts: a taxonomic study. Amsterdam: Elsevier; 2011. p. 987–1278.CrossRefGoogle Scholar
  3. 3.
    Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008–2009. Antimicrob Agents Chemother. 2011;55:561–6.Google Scholar
  4. 4.
    Johnson EM. Rare and emerging Candida species. Curr Fungal Infect Rep. 2009;3:152–9.CrossRefGoogle Scholar
  5. 5.
    Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995;141:1507–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43:284–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Alcoba-Flórez J, Méndez-Alvarez S, Cano J, et al. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol. 2005;43:4107–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Correia A, Sampaio P, James S, Pais C. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol. 2006;56:313–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Loreto ES, Scheid LA, Nogueira CW, et al. Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia. 2010;169:431–43.PubMedCrossRefGoogle Scholar
  10. 10.
    Odds FC, Bougnoux ME, Shaw DJ, et al. Molecular phylogenetics of Candida albicans. Eukaryot Cell. 2007;6:1041–52.PubMedCrossRefGoogle Scholar
  11. 11.
    Odds FC, Jacobsen MD. Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell. 2008;7:1075–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Schmid J, Herd S, Hunter PR, et al. Evidence for a general-purpose genotype in Candida albicans, highly prevalent in multiple geographical regions, patient types and types of infection. Microbiology. 1999;145:2405–13.PubMedGoogle Scholar
  13. 13.
    Zhang N, Upritchard JE, Holland BR, et al. Distribution of mutations distinguishing the most prevalent disease-causing Candida albicans genotype from other genotypes. Infect Genet Evol. 2009;9:493–500.PubMedCrossRefGoogle Scholar
  14. 14.
    Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses. 2001;44:437–45.PubMedCrossRefGoogle Scholar
  15. 15.
    • Odds FC. Molecular phylogenetics and epidemiology of Candida albicans. Future Microbiol. 2010;5:67–79. This review article reports important molecular epidemiological data on C. albicans clades and offers good insight into phylogenetic relationship between C. africana and C. albicans.PubMedCrossRefGoogle Scholar
  16. 16.
    Tietz HJ, Küssner A, Thanos M, et al. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J Clin Microbiol. 1995;33:2462–5.PubMedGoogle Scholar
  17. 17.
    Pasligh J, Radecke C, Fleischhacker M, Ruhnke M. Comparison of phenotypic methods for the identification of Candida dubliniensis. J Microbiol Immunol Infect. 2010;43:147–54.PubMedCrossRefGoogle Scholar
  18. 18.
    Forche A, Schönian G, Gräser Y, Vilgalys R, Mitchell TG. Genetic structure of typical and atypical populations of Candida albicans from Africa. Fungal Genet Biol. 1999;28:107–25.PubMedCrossRefGoogle Scholar
  19. 19.
    Ciardo DE, Schär G, Böttger EC, Altwegg M, Bosshard PP. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol. 2006;44:77–84.PubMedCrossRefGoogle Scholar
  20. 20.
    •• Romeo O, Criseo G. Candida africana and its closest relatives. Mycoses. 2011;54:475–86. This is the most comprehensive review that has been done on C. africana.PubMedCrossRefGoogle Scholar
  21. 21.
    • Sampaio P, Nogueira E, Loureiro AS, et al. Increased number of glutamine repeats in the C-terminal of Candida albicans Rlm1p enhances the resistance to stress agents. Antonie Van Leeuwenhoek. 2009;96:395–404. This article reports interesting genetic data on rml1 gene found in some C. africana isolates.PubMedCrossRefGoogle Scholar
  22. 22.
    •• Borman AM, Szekely A, Linton CJ, et al. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol. 2013;51:967–72. This article contains a huge amount of epidemiologic data on C. africana and also reports for the first time virulence experiments in this fungus.PubMedCrossRefGoogle Scholar
  23. 23.
    Romeo O, Criseo G. Morphological, biochemical and molecular characterisation of the first Italian Candida africana isolate. Mycoses. 2009;52:454–7.PubMedCrossRefGoogle Scholar
  24. 24.
    • Romeo O, Criseo G. Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana. J Clin Microbiol. 2009;47:212–4. This is an important epidemiological study on C. africana in Italy.PubMedCrossRefGoogle Scholar
  25. 25.
    Alonso-Vargas R, Elorduy L, Eraso E, et al. Isolation of Candida africana, probable atypical strains of Candida albicans, from a patient with vaginitis. Med Mycol. 2008;46:167–70.PubMedCrossRefGoogle Scholar
  26. 26.
    Mendling W, Krauss C, Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses. 2004;47:136–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Dieng Y, Sow D, Ndiaye M, et al. Identification de trois souches de Candida africana. Journal de Mycologie Médicale. 2012;22:335–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Nnadi NE, Ayanbimpe GM, Scordino F, et al. Isolation and molecular characterization of Candida africana from Jos, Nigeria. Med Mycol. 2012;50:765–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Gumral R, Sancak B, Guzel AB, Saraçlı MA, Ilkit M. Lack of Candida africana and Candida dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms. Mycopathologia. 2011;172:73–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Rosenvinge FS, Dzajic E, Knudsen E, et al.: Performance of matrix-assisted laser desorption-time of flight mass spectrometry for identification of clinical yeast isolates. Mycoses. 2013;56:229-35.Google Scholar
  31. 31.
    Romeo O, Criseo G. First molecular method for discriminating between Candida africana, Candida albicans and Candida dubliniensis by using hwp1 gene. Diagn Microbiol Infect Dis. 2008;62:230–3.PubMedCrossRefGoogle Scholar
  32. 32.
    Lockhart SR. Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis? J Clin Microbiol. 2011;49:4415.PubMedCrossRefGoogle Scholar
  33. 33.
    Czaika VA, Czaika GK, Schmalreck AF, Tietz HJ. Empfindlichkeitsmuster der neuen spezies Candida africana. Mykologie Forum. 2003;3:13–8.Google Scholar
  34. 34.
    Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9:327–35.Google Scholar
  35. 35.
    Huang G. Regulation of phenotypic transitions in the fungal pathogen Candida albicans. Virulence. 2012;3:251–61.PubMedCrossRefGoogle Scholar
  36. 36.
    •• Noble SM, French S, Kohn LA, Chen V, Johnson AD. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet. 2010;42:590–8. This is a very important article because reports a screen of C. albicans mutants that demonstrates that pathogenesis can be dissociated from morphological switching and in vitro growth rate.PubMedCrossRefGoogle Scholar
  37. 37.
    • Romeo O, De Leo F, Criseo G. Adherence ability of Candida africana: a comparative study with Candida albicans and Candida dubliniensis. Mycoses. 2011;54:57–61. This article reports data on C. africana adhesion to human cells and biofilm formation in vitro.CrossRefGoogle Scholar
  38. 38.
    Jacobsen MD, Boekhout T, Odds FC. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea. FEMS Yeast Res. 2008;8:764–70.PubMedCrossRefGoogle Scholar
  39. 39.
    Magee PT. Fungal pathogenicity and morphological switches. Nat Genet. 2010;42:560–1.PubMedCrossRefGoogle Scholar
  40. 40.
    Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999;283:1535–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell. 2006;5:1604–10.PubMedCrossRefGoogle Scholar
  42. 42.
    Nobile CJ, Schneider HA, Nett JE, et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol. 2008;18:1017–24.PubMedCrossRefGoogle Scholar
  43. 43.
    Bruno VM, Kalachikov S, Subaran R, et al. Control of the Candida albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog. 2006;2:e21.Google Scholar
  44. 44.
    Miyazaki T, Inamine T, Yamauchi S, et al. Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata. FEMS Yeast Res. 2010;10:343–52.PubMedCrossRefGoogle Scholar
  45. 45.
    • Jackson AP, Gamble JA, Yeomans T, et al. Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res. 2009;19:2231–44. This article compares genomes of C. albicans and hypovirulent species C. dubliniensis and shows reductive evolution and gene loss in this latter species.PubMedCrossRefGoogle Scholar
  46. 46.
    Magee BB, Sanchez MD, Saunders D, Harris D, Berriman M, Magee PT. Extensive chromosome rearrangements distinguish the karyotype of the hypovirulent species Candida dubliniensis from the virulent Candida albicans. Fungal Genet Biol. 2008;45:338–50.PubMedCrossRefGoogle Scholar
  47. 47.
    Asakura K, Iwaguchi S, Homma M, et al. Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata. J Gen Microbiol. 1991;137:2531–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Iwaguchi SI, Sato M, Magee BB, et al. Extensive chromosome translocation in a clinical isolate showing the distinctive carbohydrate assimilation profile from a candidiasis patient. Yeast. 2001;18:1035–46.PubMedCrossRefGoogle Scholar
  49. 49.
    Nowrousian M. Next-generation sequencing techniques for eukaryotic microorganisms: sequencing-based solutions to biological problems. Eukaryot Cell. 2010;9:1300–10.PubMedCrossRefGoogle Scholar
  50. 50.
    Dong Y, Xie M, Jiang Y, et al. Sequencing and automated whole-genome optical mapping of the genome of a domestic goat (Capra hircus). Nat Biotechnol. 2012;31:135–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Orazio Romeo
    • 1
  • Hans-Jürgen Tietz
    • 2
  • Giuseppe Criseo
    • 1
  1. 1.Department of Environmental and Biological SciencesUniversity of MessinaMessinaItaly
  2. 2.Institut für PilzkrankheitenBerlinGermany

Personalised recommendations